VEGFA and neoplasm: Recently, EVs from tumour cells are reported to act on residual fibroblasts or other cells to induce CAF differentiation, then promoting angiogenesis by secreting angiogenic factors, including VEGF, TGF‐β, FGF2, MMP9 and MMP2.70